Trial Profile
Effect of Cytochrome P450 2B6 Genetic Polymorphism and Voriconazole on CYP2B6 Activity in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary) ; Efavirenz
- Indications HIV-1 infections
- Focus Pharmacodynamics; Pharmacogenomic; Pharmacokinetics
- 08 Apr 2013 Actual end date changed from Apr 2011 to Apr 2013 as reported by ClinicalTrials.gov.
- 12 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 12 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.